ConTTRibute: A Global Observational Multicenter Long-Term Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
ConTTRibute: A Global Observational Multicenter Long-Term Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
The purpose of this study is to:
Inclusion Criteria:
Exclusion Criteria:
clinicaltrials@alnylam.com1-877-ALNYLAM
clinicaltrials@alnylam.com1-877-256-9526